CoChat

Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats I: Magnetic resonance imaging

Open access
van Vliet, Erwin A., Otte, Willem M., Wadman, Wytse J., Aronica, Eleonora, Kooij, Gijs, de Vries, Helga E., Dijkhuizen, Rick M., Gorter, Jan A. · 2016 · Epilepsia
Cited by 65

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Objective: The mammalian target of rapamycin (m TOR) pathway has received increasing attention as a potential antiepileptogenic target. Treatment with the m TOR inhibitor rapamycin after status epilepticus reduces the development of epilepsy in a rat model. To study whether rapamycin mediates this effect via restoration of blood–brain barrier (BBB) dysfunction, contrast‐enhanced magnetic resonance imaging (CE‐MRI) was used to determine BBB permeability throughout epileptogenesis. Methods: Imaging was repeatedly performed until 6 weeks after kainic acid–induced status epilepticus in rapamycin (6 mg/kg for 6 weeks starting 4 h after SE) and vehicle‐treated rats, using gadobutrol as contrast agent. Seizures were detected using video monitoring in the week following the last imaging session. Results: Gadobutrol leakage was widespread and extensive in both rapamycin and vehicle‐treated epileptic rats during the acute phase, with the piriform cortex and amygdala as the most affected regions. Gadobutrol leakage was higher in rapamycin‐treated rats 4 and 8 days after status epilepticus compared to vehicle‐treated rats. However, during the chronic epileptic phase, gadobutrol leakage was lower in rapamycin‐treated epileptic rats along with a decreased seizure frequency. This was confirmed by local fluorescein staining in the brains of the same rats. Total brain volume was reduced by this rapamycin treatment regimen. Significance: The initial slow recovery of BBB function in rapamycin‐treated epileptic rats indicates that rapamycin does not reduce seizure activity by a gradual recovery of BBB integrity. The reduced BBB leakage during the chronic phase, however, could contribute to the decreased seizure frequency in post–status epilepticus rats treated with rapamycin. Furthermore, the data show that CE‐MRI (using step‐down infusion with gadobutrol) can be used as biomarker for monitoring the effect of drug therapy in rats.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.13246

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
van Vliet, E. A., Otte, W. M., Wadman, W. J., Aronica, E., Kooij, G., de Vries, H. E., Dijkhuizen, R. M., & Gorter, J. A.
Venue
Epilepsia
Publisher
Wiley
Published
2015-12-22
Volume
57
Issue
1
Pages
59-69
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2202300859
Cited by
65
References
6
FWCI
4.58
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.